Skin, hair and beyond: the impact of menopause.
Menopause
exposome
hair
hormone replacement therapy
hormones
mucosa
perimenopause
skin
Journal
Climacteric : the journal of the International Menopause Society
ISSN: 1473-0804
Titre abrégé: Climacteric
Pays: England
ID NLM: 9810959
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
pubmed:
5
4
2022
medline:
9
9
2022
entrez:
4
4
2022
Statut:
ppublish
Résumé
The skin is an endocrine organ and a major target of hormones such as estrogens, androgens and cortisol. Besides vasomotor symptoms (VMS), skin and hair symptoms often receive less attention than other menopausal symptoms despite having a significant negative effect on quality of life. Skin and mucosal menopausal symptoms include dryness and pruritus, thinning and atrophy, wrinkles and sagging, poor wound healing and reduced vascularity, whereas skin premalignant and malignant lesions and skin aging signs are almost exclusively caused by environmental factors, especially solar radiation. Hair menopausal symptoms include reduced hair growth and density on the scalp (diffuse effluvium due to follicular rarefication and/or androgenetic alopecia of female pattern), altered hair quality and structure, and increased unwanted hair growth on facial areas. Hormone replacement therapy (HRT) is not indicated for skin and hair symptoms alone due to the risk-benefit balance, but wider potential benefits of HRT (beyond estrogen's effect on VMS, bone, breast, heart and blood vessels) to include skin, hair and mucosal benefits should be discussed with women so that they will be able to make the best possible informed decisions on how to prevent or manage their menopausal symptoms.
Identifiants
pubmed: 35377827
doi: 10.1080/13697137.2022.2050206
doi:
Substances chimiques
Estrogens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM